Prenatal antipsychotic exposure and neuromotor performance during infancy. - Wikidata - awgldk - TriplyDB

Prenatal antipsychotic exposure and neuromotor performance during infancy.

Prenatal antipsychotic exposure and neuromotor performance during infancy.

http://www.wikidata.org/entity/Q36467152

about

Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).Recent advances in understanding maternal perinatal mood disorders.Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.Biologically based treatment approaches to the patient with resistant perinatal depression.Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Translational toxicology: a developmental focus for integrated research strategies.Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy.The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.Use of psychotropic medication during pregnancy and the postpartum period.Antipsychotic use in pregnancy.Bipolar Disorder in Pregnancy and Postpartum: Principles of Management.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Valproic Acid in Women and Girls of Childbearing Age.Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study.Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark.Risk of impaired cognition after prenatal exposure to psychotropic drugs.Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men.

P2860

Q26774013-A8A9136A-ABCE-420C-BBB6-CABB087F2D26 Q26824299-DDB52178-4798-4410-AABA-6907BA9FFC17 Q30249670-5EC91522-0B4C-483E-A67B-72ECDCED7499 Q31056264-28EA0418-9368-4A13-894D-724E3C6FDED6 Q33806570-7DE0BE74-9625-4046-9591-D5BAB3AA3FEA Q33907544-937CBE17-9823-4F72-96AF-39B7CF43C2DC Q34799159-4C4F4456-3188-4323-88B7-1FE9BA37895C Q34823805-5B17C169-E5FA-4A03-BEEE-625778E50197 Q35002347-E063FC19-3759-45BA-8BC1-391D9D0A3463 Q35688301-83629E16-2821-429A-AD65-3D9CB0CE5BD3 Q36547279-1671043B-31C6-43EC-AB31-7DEA3B9EBA30 Q37011220-2A7C5F59-4677-457F-9C94-F9FD1E741CFF Q37026000-C4E0911F-A07C-40C6-A2F8-152F93307349 Q38155675-E9EC6280-BBDD-40AE-9F24-73CA713885DF Q38498051-258EF244-0DF2-42FF-A536-22B06F152B0B Q38701750-36FA47E5-FE26-4C5F-B93B-4B0E1C9461E3 Q38811512-D850072F-9992-417B-BA46-0AEE196A0A99 Q39446928-FCF5AC40-B6DE-42CC-B0D1-75C2C0358F9C Q44677911-F8150110-5FB3-4002-8151-001CA5311FD4 Q47162514-A9246535-5735-41DD-B46C-B3FB8759680F Q47360060-D3691A8C-3801-4A4A-A2F9-B843A7109261 Q48205231-D91F118B-0B91-42B3-B818-0D97355B9873

P2860

Prenatal antipsychotic exposure and neuromotor performance during infancy.

http://www.wikidata.org/entity/Q36467152

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Prenatal antipsychotic exposure and neuromotor performance during infancy.

@ast

Prenatal antipsychotic exposure and neuromotor performance during infancy.

@en

type

label

Prenatal antipsychotic exposure and neuromotor performance during infancy.

@ast

Prenatal antipsychotic exposure and neuromotor performance during infancy.

@en

prefLabel

Prenatal antipsychotic exposure and neuromotor performance during infancy.

@ast

Prenatal antipsychotic exposure and neuromotor performance during infancy.

@en

P1433

Q36467152-E26D20AB-0E1B-4D23-B2B5-7A635DBDAC13

P1476

Q36467152-D7EF041C-A521-4D30-A12B-5F316F6B98CC

P2093

Q36467152-54FD8E9D-9701-4224-BBFA-4DE7FB7B5390

Q36467152-8730EE18-E6F7-4E8C-90E7-2D267C957E78

Q36467152-B300C669-8A86-4462-9A28-C1A5C6ADC9F2

Q36467152-B6D9CA7D-D0BC-4AB8-9B07-74D1017B796D

Q36467152-D90B3498-CC45-4241-84BC-6D71CF52DD9E

P2860

Q36467152-076D3D42-A73A-4723-B328-1798B98F3270

Q36467152-0FF8886E-3AAF-4A5E-A2F8-121EDE8D5F61

Q36467152-12A3493F-4E79-4757-8288-810BEDA11EBF

Q36467152-193AD146-89CE-45A4-A491-89BBF70A5171

Q36467152-2D81C795-DF62-4A1E-900B-F1846D1815E0

Q36467152-3138F859-97AC-4B0E-B67A-6C034A26F136

Q36467152-3BB21A86-5838-4B9D-A873-66CFF794FB6B

Q36467152-49120034-D2AD-4C39-BE4C-EEC1B58EE37D

Q36467152-4C552E9F-7D6D-4C24-B693-4F17D3E3B436

Q36467152-5F372961-6020-4FE9-94FC-462FC3A29349

P304

Q36467152-391BC07E-1ACC-480B-8B8B-BEE5756DDB4A

P31

Q36467152-BC847813-B257-45BD-B7FA-56505B5EF424

P356

Q36467152-B3E18CA1-CA54-4359-956E-4CA2D4DA74C9

P407

Q36467152-3F5E643C-EB0F-423D-BD32-8AD7FF8370C4

P433

Q36467152-DBF6AA47-F397-4B33-8108-FC2AAA1FF0D1

P478

Q36467152-31E1C461-5524-44B2-BC96-74FAE30A425D

P577

Q36467152-3AC870DF-7373-4842-AE24-7EC8A8B29AF8

P5875

Q36467152-A87567DA-3FA3-4125-9FCF-504DF5766D71

P698

Q36467152-46A61808-2CD8-48CC-A3F4-0E8413174569

P932

Q36467152-CB47BBEF-D93E-4118-9897-09768A12AD44

P356

ARCHGENPSYCHIATRY.2012.160

P1433

JAMA Psychiatry

P1476

Prenatal antipsychotic exposure and neuromotor performance during infancy.

@en

P2093

D Jeffrey Newport

http://www.w3.org/2001/XMLSchema#string

Jamie L LaPrairie

http://www.w3.org/2001/XMLSchema#string

Katrina C Johnson

http://www.w3.org/2001/XMLSchema#string

Patricia A Brennan

http://www.w3.org/2001/XMLSchema#string

Zachary N Stowe

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

Antipsychotic therapy during early and late pregnancy. A systematic review.

Validity of depression rating scales during pregnancy and the postpartum period: impact of trimester and parity

Neurotransmitters and neuromodulators during early human development.

Functional imaging studies on dopamine and motor control.

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Maternal use of antipsychotics in early pregnancy and delivery outcome.

Infant neuromotor assessments: a review and preview of selected instruments.

Significant changes in antipsychotic drug use during pregnancy.

Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects.

P304

787-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHGENPSYCHIATRY.2012.160

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223986539

http://www.w3.org/2001/XMLSchema#string

P698

22474072

http://www.w3.org/2001/XMLSchema#string

P932

4714592

http://www.w3.org/2001/XMLSchema#string